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We recently described a family with chromosome 17-linked dementia, characterized clinically by disinhibition-dementia- 
parkinsonism-amyotrophy complex. We report now the neuropathology of 6 affected family members. This included 
semiquantitative scoring of neuronal loss, gliosis, and spongiosis and immunocytochemical and ultrastructural character- 
ization of neuronal and glial inclusions. The changes consisted of circumscribed neuronal loss, gliosis, and spongiosis 
of limbic neocortical areas and frontal, temporal, and occipital association areas. Similar changes were present in subcorti- 
cal nuclei, most severe in the substantia nigra, but also involved the ventral striatum and amygdala. The hippocampus 
was spared except for degeneration of the afferent perforant tract, secondary to entorhinal nerve cell loss. hgyrophilic 
neuronal inclusions, with a characteristic immunocytochemical profile, were found in brainstem nuclei, hypothalamus, 
and basal ganglia. Ultrastructurally, in 3 patients these inclusions showed hitherto undescribed abnormally assembled 
filaments. Glial cytoplasmic inclusions were widespread in white matter structures. Immunocytochemistry failed to 
demonstrate the protease-resistant prion protein. The pathology appears to be unique, involving various cortical and 
subcortical structures, and is consistent with the clinical findings of Kliiver-Bucy-like syndrome, parkinsonism, and 
frontal lobe dementia. For this entity we suggest the term “chromosome 17-linked dementia.” 
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We recently reported a family in which 13 members 
had varying degrees of disinhibition, parkinsonism, de- 
mentia, and in some members, aniyotrophy. We sug- 
gested the name “disinhibition-dementia-parkinson- 
ism-amyotrophy complex” [ 11. In 6 members from this 
family who underwent autopsy, the onset of obvious 
disease occurred at a mean age of 44 years. Initially, 
the patients showed a range of personality and behav- 
ioral changes. Disinhibition, a predominant feature, 
manifested as a Kluver-Bucy-like syndrome with 
hyperihyposexuality and oral tendency, alcoholism and 
aggressiveness. Social withdrawal, depression, and a 
schizophrenia-like picture occurred in some patients. 
These features were found in a variety of combinations 
and varied over time in individual patients. Memory 
was eventually affected in all, with relative preservation 
of orientation, speech, and calculation ability until late 
in the disease. Parkinsonism and cognitive deteriora- 
tion led to a rigid, akinetic mute state. Amyotrophy 
was obvious in 1 patient. The mean duration of the 
disorder to death was 14 years. 
A genetic etiology was suspected because of the familial 
clustering of the disorder. Linkage analysis by typing of 
simple sequence repeat polymorphisms in 33 family 
members localized the disease locus to 17q21-22 [l-31, 
the same locus to which familial progressive subcortical 
gliosis recentlywas linked 141. The disorder is transmitted 
as a highly penetrant autosomal dominant trait. As in 
other familial neurodegenerative disorders [5-9], there 
appear to be sporadic forms with clinical and pathological 
phenotypes similar to the chromosome 17-linked disease 
reported here [3].  However, the genetic etiologic relation- 
ship of sporadic disease with a similar pathology to the 
present disease is unknown. 
We reviewed the pathological findings in all avail- 
able members with familial disease to id en ti^ charac- 
teristic and consistent features that could be correlated 
with the clinical features of this disease [I]. 
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Materials and Methods 
Clinical information obtained in the 6 affected family mem- 
bers reported here included results from neurological exami- 
nation, neuropsychological tests, and detailed mental status 
assessments (memory, orientation, construction, naming, and 
other language functions). These findings have been reported 
elsewhere [I]. 
Neuropathology 
The brains from the 6 members (111-33, 111-35, 111-37, III- 
39, 111-53, and 111-57 [I]) were inspected grossly at autopsy. 
In 1 member (111-35) the brain was hemidissected and one 
hemisphere was frozen. One patient (111-53) was described 
in a previous case report [ 101. The brains were fixed in for- 
malin. A total of 46  neuroanatomical sites variably available 
in the individuals (Table) were examined by light micros- 
copy. Paraffin sections were stained with hematoxylin-eosin, 
cresyl violet-Luxol fast blue-eosin, phosphotungstic acid 
and hematoxylin, congo red, and Bielschowsky’s silver im- 
pregnation. The severity of neuronal loss, gliosis, and spon- 
giosis was scored on a scale from 0 to + + +; (0 = normal, 
+ = mild; + + = moderate, and + + + = severe) by con- 
sensus (A. A. F. s., C. K., and C. D.’A.). The presence of 
neuronal tangle-like inclusions (considered either as Alzhei- 
mer’s disease [AD] or non-AD tangles), neuritic plaques, bal- 
looned neurons, and spheroids were noted as present (+) or 
absent (0). 
Irn rnunocytochernistry 
Five-micrometer-thick sections from most sites were deparaf- 
finized and immunostained by the avidin-biotin-peroxidase 
complex (ABC) method [11] with a Vectastain ABC kit 
(Vector, Burlingame, CA). The following primary antibodies 
were applied: polyclonal rabbit antitau (1 : 100) (Sigma 
Chemical, St. Louis, MO), polyclonal rabbit anti-human 
ubiquitin (1 : 100) (Dako, Carpenreria, CA), monoclonal 
anti-phosphorylated neurofilament (1 : 250) (Sternberger 
Monoclonals, Baltimore, MD), monoclonal mouse anti- 
human beta-amyloid (1 : 100) (Dako), and polyclonal rabbit 
anti-human glial fibrillary acidic protein (GFAP) (1 : 250) 
(Sigma). Nonspecific binding was blocked by pretreatment 
with a blocking kit (Vector). Negative control samples were 
provided by omitting the primary or secondary antibody. 
Sections were incubated with the required primary antibody 
followed by the secondary reagent, including biotinylated 
anti-rabbit or anti-mouse IgG, for 30 minutes, and then with 
ABC. The sections were then subjected to peroxidase reac- 
tion containing freshly prepared 0.02 M 3,3’-diaminobenzi- 
dine-tetrachloride and 0.05% hydrogen peroxide in 0.05 M 
Tris-hydrochloric acid buffer at p H  7.6 for 10 minutes at 
room temperature. The staining was performed with a His- 
tostainer Ig instrument (Leica, Deerfield, IL). 
Electron Microscopy 
One-millimeter tissue cubes were cut from paraffin blocks 
from 3 family members (111-37, 111-39, and 111-53) con- 
taining intracytoplasmic inclusions on light microscopic ex- 
amination. These were then deparaffinized, postfixed in 
2.5% buffered glutaraldehyde followed by 1 % buffered os- 
mium tetroxide, dehydrated, and embedded in epoxy resin 
(Epon) and examined with an electron microscope. 
Irnrnunoblot Analysis of Brain Extracts 
Previously frozen tissue from 1 patient (111-35) was homoge- 
nized in nine volumes of lysis buffer (100 mM sodium chlo- 
ride, 10 mM ethylenediaminetetraacetic acid, 0.5% NP40, 
0.5% sodium deoxycholate, 10 mM Tris, p H  7.4) and ali- 
quot was digested with proteinase K (100 yglml) for 1 hour 
at 37°C. Digestion was terminated by the addition of PMSF 
(2 mM final concentration) and boiling in electrophoresis 
sample buffer (3% sodium dodecyl sulfate in 62.5 mM Tris, 
p H  6.8). Sample was resolved on 12% polyacrylamide gels, 
immunoblotted with the monoclonal antibody 3F4, which 
recognizes the prion protein (PrP) residues 109 to 112, and 
developed as previously described [ 121. 
Prion Protein Irnrnunocytocbernistry 
Paraffin sections from frontal, temporal, and parietal cortices, 
hippocampus, and cerebellum from all 6 family members 
were treated with 98% formic acid and hydrolytic autoclav- 
ing to enhance PrP immunoreactivity [13]. Sections were 
then incubated with monoclonal antibody 3F4 raised against 




T h e  clinical histories of the 6 members reported here 
have been summarized 11, 21. The clinical findings in 
a typical index patient (111-37) are briefly presented. 
A 52-year-old woman (111-37) presented with progressive 
personality change and dementia. She complained of losing 
things around the house and forgetting names and recent 
events. She had received a high school education and had 
worked as a phone receptionist. Past medical history was 
noncontriburory. Her father (11-8), paternal grandmother 
(1-15), paternal aunt (11-6), paternal uncle (11-10) [I] ,  and 
a brother (111-39) died of dementing illnesses with parkin- 
sonian features. A similar dementing-parkinsonian illness 
has since developed in another brother (111-45) and sister 
(111-41). Four other siblings and 7 children have no neuro- 
logical disease to date. 
Her family noted behavioral changes, initially seen at her 
mother’s funeral where she was unfriendly to other family 
members and tended to “shy away.” She acted in a “childish 
but affable” manner and compulsively walked the same route 
daily. She had a decreased libido and a craving for sweets, 
gaining 90 pounds over 4 years. 
At age 53 she was oriented to person, place, and time; 
was slow in calculations; and was able to recall only one 
out of three objects at 5 minutes. O n  the Wechsler Adult 
Intelligence Scale-Revised (WAIS-R) she scored an I Q  of 72, 
with a verbal score of 72 and a performance score of 67. 
Speech was normal and her motor findings were normal 
without evidence of extrapyramidal dysfunction. 
At age 54 she was alert, attentive, and oriented to person, 
place, and time. She repeated nine digits forward and four 
backward. She named 1 out of 10 pictured objects and body 
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Neuropulhological Findings in Patients with Chromosome 17-Linked Dementiad 
Intraneuronal Inclusionsh 
Ballooned Neuronal 
Gliosis Spongiosis AD Tangles‘ Non-AD Tangles Neuronsh Spheroidsh 
- 
Anatomical Site Loss 
Cortices 
Entorhinal cortex 
Anterior temporal cortex 
Prefrontal cortex 
Anterior ci ngulate 
Posterior cingulate [3] 
Insular cortex 
I’repiriform cortex 141 
Occipital cortex [ 5 ]  (area 17) 
Occipital cortex [3] (area 18) 
Parietal cortex [3] 





Dentate fascia [ 5 ]  












Mamillary body 133 
Ventral hypothalamus 141 





Suhstantia n i p  [5] 
Pars compacra 
Pars rericularis 
Red nucleus 151 
Locus ceruleus [4] 
Pontine nuclei [5] 
Suhstantia innominata [5] 
Periaqueductal gray 
Third nucleus 
Inferior olivaiy nucleus [4] 
Cerebellar cortex [4]“ 
Cerebellar dentate nucleus [4Id 
Anterior horn 
Internmediolateral column 


















































































































































































































































‘Scoring of the severity of neuronal l o s b ,  gliosis and spongiosis: 0 = normal; + = mild; + + = moderate; + + + = severe change. The 
numbers within brackets after the anaromical site indicate the number of cases available. 
hThe presence of AD tangles, non-AD tangles, ballooned neurons, and spheroids is indicated with “+” and their absence with “0.” 
‘Very occasional AD tangles were found in 4 cases (111-33, 111-35, 111-37, and 111-53). 
dCase IIJ-37 showed extensive remote hypoxic/ischemic changes of the hippocampus and cerebellum and is not included in the scores. 
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parts. Repetition was normal. Constructions were poor. At 
5 minutes she recalled none of three objects. On the WAIS-R 
she produced a verbal I Q  of 74 and a performance I Q  of 
65. She scored poorly on fund of general information and 
verbal abstract reasoning. Her behavior was childish and im- 
pulsive and she had difficulty following instructions. Cranial 
nerve findings were normal. A decreased arm swing, difficulry 
with rapid alternating movements, a positive glabellar tap, 
and bilateral palmomental responses were noted. 
The following were normal: complete blood cell count, 
erythrocyte sedimentation rate, electrolytes, creatinine level, 
liver and thyroid function, electrocardiogram, coagulation 
screen, urinalysis, and cerebrospinal fluid (CSF), with a pro- 
tein concentration of 45 mg/dl, glucose level of 59 mg/dl, 
0 white blood cells, 1 red blood cell, and a CSF opening 
pressure of 150 mm HzO. The electroencephalogram was 
normal. 
Computed tomography at the age of 58 years showed dif- 
fuse cerebral atrophy, especially prominent in the frontal and 
temporal lobes. Sequential regional cerebral blood flow stud- 
ies performed at ages 55, 56, and 57 revealed an initial decre- 
ment in cerebral blood flow affecting the frontal lobes, with 
later development of hypoperfusion of the posterior lobes. 
Dementia progressed and was accompanied by slowing of 
movements with a stiff, shuffling gait. Eventually swallowing 
difficulties with drooling and muteness developed. By 59 
years, she was bed bound and incontinent. Contractures of 
the elbows, knees, and hips had developed. Full extraocular 
movements were present. Reflexes were symmetrical and 
plantar reflexes were flexor. She followed no commands and 
remained mute, apart from groaning and grimacing in re- 
sponse to painful stimuli. She died at age 60. 
Neuropatho Logy 
GROSS FINDINGS. Brain weights of the 6 patients 
ranged from 970 to 1,350 gm. Gyral atrophy was usu- 
ally evident in anterior and inferior regions of the tem- 
poral lobes, the prefrontal areas, and the anterior cin- 
gulate gyrus, whereas the posterior frontal, parietal, and 
occipital areas appeared normal. The  hippocampus ap- 
peared unremarkable. In  the most severely affected 
members, the basal ganglia exhibited atrophy and mild 
brownish discoloration. The  brainstem appeared nor- 
mal, except for severe pallor of the substantia nigra in 
all members. The  cerebellum was not remarkable. 
MICROSCOPIC FINDINGS. Although the severity of his- 
topathological changes varied from brain to brain, their 
distribution appeared uniform. In the most severely af- 
fected cortical areas, neuronal loss and gliosis were seen 
throughout the thickness of the cortex (Fig 1). In less 
severely affected areas of cerebral cortex, the second, 
third, and sixth layers appeared to be primarily in- 
volved, with relative sparing of the fourth and fifth 
layers (Fig 2). Generally, the astrogliosis seemed to ex- 
ceed the severity of neuronal loss (see Table). The  atro- 
phy of the superficial cortical layers was associated with 
laminar spongiosis commonly confined to the contigu- 
Fig I .  Entorhinal cortex ?om Case III-35 showing marked 
neuronal loss and dense gliosis throughout the thickness o f  the 
cortex. In the superjicial layers I and Z there is  mild Ton- 
giosis. (Phosphotungstic acid and hematoxylin, X 56 before 
I I % reduction.) 
ous deep and superficial parts of the first and second 
layers (see Fig 1). The most severely affected areas of 
the cerebral cortex were, in descending order, the pre- 
piriform, anterior temporal, entorhinal, visual associa- 
tion (area 18), anterior cingulate, prefrontal, and insu- 
lar regions (see Table). The  white matter underlying 
the most severely affected cortices showed axonal loss, 
myelin pallor, and mild isomorphic astrogliosis with 
relative sparing of the U fibers. Clustering of astroglial 
elements was not seen in subcortical areas (see Fig 2). 
The  posterior cingulate gyrus, parietal cortex (available 
from 3 members), and visual cortex (area 17) (available 
from 5 members) did not show neuronal loss or sig- 
nificant gliosis. The  motor cortex, available from only 
one of the most severely affected patients (111-35), 
showed no neuronal loss or gliosis. In all specimens, 
a striking feature was the sharp demarcation between 
severely affected cortices and seemingly normal cortex. 
This was most pronounced between the anterior cingu- 
late gyrus and the medial frontal cortex (Fig 3 ) ,  and 
between areas 18 and 17 of the occipital cortex. Af- 
fected areas showed occasional ballooned neurons and 
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Fig 2. Anterior temporal cortex 30.1 Case 11'7-31 showing 
fibrillay gliosis of  layerx I to 3 and 6 whereas layerr 4 and 
5 are relatively pared. Suhcortical white matter shows no gli- 
osis. (GLid fibdlagi aridic protein immunostairiin~ X 48.) 
~~ 
Fig 3. Case 111-35. There is moderdite degeneration and atro- 
phy of the anterior ringzdizte ~ y r ~ s .  The neighboring superior 
fioontal gyrus appears virtually normal, demonstrating the 
shav demarcation o f  involved cortices. (C'regd violet -phorpho- 
tungstic acid and hematoxylin, X I 0  b+re 28% reduction.) 
Fig 4. Phosphotungstic acid and hematoxylin-stained section 
of the subiculum in Case 711-53 demonstrating marked gliosis 
o f  the crossing perforant watt (arrowheads) and adjacent 
molecular layer oj. the dentate facia (arrows). (Glial $&/la y 
acidic protein immunostain, X 54 befire 30% reduction.) 
spheroids. The latter appeared to correlate with the se- 
verity of the cortical changes. The hippocampal forma- 
tion showed relative sparing with no or only mild neu- 
ronal loss in cornu ammonis CA1 to CA3, subiculum, 
and prosubiculum. Severe gliosis and axonal loss af- 
fected the perforant tract (Fig 4 )  and the molecular 
layer of the dentate fascia. There was mild neuronal 
loss and gliosis of the dentate fascia also involving the 
adjacent areas of CA4. In 1 patient (111-39), abnormali- 
ties in the hippocampus were confounded by extensive 
remote hypoxic/ischemic loss of pyramidal neurons 
(see Table). 
The most severely affected subcortical structures 
were, in descending order, the amygdala, substantia ni- 
gra (Fig 5), ventral globus pallidus, periaqueductal 
gray, ventral putamen, ventral hypothalamus, and cau- 
date nucleus (see Table). The locus ceruleus, available 
from 4 members, showed mild neuronal loss and glio- 
sis. The pontine nuclei were unremarkable, the red nu- 
cleus was only mildly affected, and the thalamic nuclei 
and substantia innominata were minimally involved. In 
all specimens, the basal ganglia showed a gradient in 
the severity of neuronal loss and gliosis. The rostra1 
and ventral parts of the caudate nucleus, nucleus ac- 
cumbens, putamen, medial pallidum, and claustrum 
were most severely affected by neuronal loss and gliosis, 
whereas the caudal and dorsal parts of the basal ganglia 
appeared virtually normal. 
Mild neuronal loss was found in the inferior olivary 
nucleus and dorsal vagus nucleus. The cerebellar den- 
tate nucleus and cortex appeared normal (see Table). 
Mild to moderate loss of motor neurons and gliosis 
was found in 2 (111-39 and 111-53) o f  3 members from 
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Fig 5. Case III-39. Photomicrograph of substantia nigra pars 
compuctu, showing un occasional pigmented neuron, intense 
gliosis, and f lee  melanin pigment (arrows). (Phosphotungstic 
acid and hematoxylin, X 230 before 20% reduction.) 
whom the spinal cord was available. One of these (III- 
39) also showed mild neuronal loss of the intermedio- 
lateral column. 
The hippocampus and cerebral cortex showed insig- 
nificant numbers of neurofibrillary tangles or neuritic 
plaques of the Alzheimer type (see Table). No Lewy 
bodies were demonstrated in any of the samples. 
In all 6 family members, argyrophilic neuronal cyto- 
plasmic inclusions were seen in several subcortical 
structures, most commonly in the third nerve nucleus 
(Fig 6), followed by the dorsal raphe nucleus, ventral 
hypothalamus, subthalamic nucleus, periaqueductal 
gray, pars compacta of the substantia nigra, red nu- 
cleus, and globus pallidus, The inclusions stained in- 
tensely with Bielschowsky’s silver impregnation and 
appeared by light microscopy to be composed of hap- 
hazardly arranged spicules (see Fig 6). 
In addition, oligodendroglial argyrophilic tangle-like 
inclusions were seen in the white matter, the external 
capsule, ansa lenticularis, corpus callosum, and brain- 
stem. 
Mild congophilic angiopathy was found in menin- 
geal vessels of the occipital and parietal lobes in 1 brain 
(111-35). 
1MMUNOCYTOCHEMlCAL FINDINGS. The subcortical 
neuronal inclusions stained positive for phosphorylated 
neurofilament (see Fig 6) and ubiquitin, whereas they 
were negative for beta-amyloid and tau and were there- 
fore considered non-AD tangles. Occasional tau- and 
beta-amyloid-positive tangles were considered AD tan- 
gles (see Table). Ballooned neurons stained positive for 
phosphorylated neurofilaments and variably positive 
for ubiquitin and tau. In areas of cortical neuronal loss 
Fig 6. (a) Motor neuron of the third nucleus from Case III- 
35 showing spicule-like argyrophilic inclusion. (b) Similar 
inclusions staining positive for phospho ylated neurofilament 
in a dorsal raphe neuron. (Bielschowsky silver impregnation 
and antiphosphorylated neurojhment immunostain, respec- 
tive&; X 980.) 
and gliosis, numerous ubiquitin-positive and to a lesser 
degree, tau-positive granules and spheroids were seen. 
The oligodendroglial argyrophilic inclusions stained 
positive for ubiquitin and tau (Fig 7), whereas they 
were negative for beta-amyloid, phosphorylated neu- 
rofilament, and GFAP. 
ELECTRON MICROSCOPY. Intraneuronal inclusions 
were identified ultrastructurally in 3 brains and con- 
sisted of 10- to 14-nm filaments showing a three- 
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Fig Z Ol~odend~~oglial f ~ r i l ~  y inclusions in Case III-33. 
(a) The inclusion ic stained with (a) antiubiquitin and (6) 
with antitau immunostains. (X 980.) 
dimensional lattice-like arrangement with a variable 
periodicity (Fig 8). The inclusions demonstrated in oli- 
godendroglial cells showed parallel tubular structures 
measuring approximately 14 to 17 nm in diameter. 
IMMUNOBLOT ANALYSIS. Western blot analysis of 
brain extracts from the cerebellum of 1 member (III- 
35) failed to detect protease-resistant PrP (Fig 9). 
PRION PROTEIN. No immunoreactive deposits of PrP 
were detected in any of the sections from the 6 brains. 
Discussion 
The degree of cerebral atrophy varied among family 
members. The prefrontal and anterior temporal lobes 
were severely and consistently affected, with a striking 
preservation of the hippocampal formation. The atro- 
phy was symmetrical and showed a knife edge-like pat- 
tern in severely affected areas. 
Fig 8. Electron micrograph o f  intraneuronal inclusions in the 
third nucleus f;om Case ID-33 demonstrating periodically 
arranged neuroflaments (a). (6) Higher magnijcation demon- 
strating a three-dimensional arrangement of filaments measur- 
ing between 10 and 14 nm. (a: X 28,500; 6: X 90,800 
before 22% reduction.) 
The characteristic pathological changes were neu- 
ronal loss, astrogliosis, and laminar spongiosis of the 
limbic and association cortices, often in a sharply cir- 
cumscribed fashion. Similar changes also involved vari- 
ous subcortical structures. 
The most striking finding consisted of neuronal in- 
tracytop!asmic inclusions consisting of hitherto unde- 
scribed phosphorylated neurofilaments arranged in lat- 
tice-like formations. They were common in brainstem 
nuclei, hypothalamus, and basal ganglia. Their distri- 
bution was similar to that of tangles in progressive su- 
pranuclear palsy (PSP) [14, 151, although their fine 
structural features appeared unique and different from 
the straight tubular structures characterizing PSP tan- 
gles [ 16, 171. Immunocytochemically they were posi- 
tive for phosphorylated neurofilament and ubiquitin 
but negative for tau and beta-amyloid. Since similar 
microfilamentous inclusions have not been described 
previously, they may serve as a histopathological 
marker for chromosome 17-linked dementia (Ch- 
17D). An unexpected finding was oligodendroglial cy- 
toplasmic inclusions, so-called glial cytoplasmic inclu- 
sions (GCIs), with an immunocytochemical profile 
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PK - +  - +  - +  
49.5  - 
32.5  - 
18.5 - 
1 2  3 4  5 6  
Fig 9. Western blot imrnunodetection of prion protein before 
(lanes 1, 3, and 5) and after proteinase K (PK) digestion 
(lanes 2, 4, and Q. Lanes 1 and 2: cerebellum from a nor- 
mal age-matched human brain; lanes 3 and 4: cerebellum 
)om a subject with a sporadic Creutzfeldt-/akob disease; 
lanes 5 and 6: cerebellum from Case (11-35 with chromosome 
17-linked dementia. In this subject, as in the control, pro- 
tease-resistant prion protein was not detected. In this experi- 
ment a volume equivalent to 0.3 mg o f  wet tissue was loaded 
in each lane. The same result was obtained loading a volume 
equivalent to 2 mg of wet tissue. 
identical to those described in multiple-system at- 
rophy (MSA) [ 18-20]. This observation suggests that 
GCIs are not specific for MSA [18].  They have also 
been observed in cortico-basal ganglionic degeneration 
(CBD) 1211, PSP [22-231, and spinocerebellar atro- 
phy type 1 (SCA1) with multiple-system degeneration 
The distribution of the present changes suggests 
involvement of cortical and subcortical structures en- 
compassing cortico-basal ganglionic circuits such as 
the entorhinal, anterior temporal, and cingulate projec- 
tions to the ventral striatum [25, 261, as well as projec- 
tions from the piriform cortex and amygdala to the 
ventral hypothalamus, entorhinal cortex, and temporal 
association cortex [25, 261. Furthermore, involvement 
of the mesolimbic system may be postulated, involving 
projections from the ventral tegmental area of the sub- 
stantia nigra to the anterior cingulate, entorhinal, and 
insular cortices 127-291. 
The severe involvement of the anterior temporal cor- 
tex, including the amygdala, is likely to correlate with 
the personality changes characterized by hyperorality 
and hypo/hypersexuality consistent with the Kliiver- 
Bucy syndrome [30, 311. The changes of prefrontal 
cortex and apparent deafferentation of the hippocam- 
pal formation are most likely responsible for the frontal 
lobe release signs, frontal lobe dementia, and eventually 
global dementia. The profound degeneration of the 
substantia nigra corresponds to the parkinsonian signs 
exhibited early in the course of the disease. The prefer- 
~241. 
ential involvement of the ventral striatum is most likely 
associated with the pathology in the association cortices 
and neocortical limbic structures [25, 261. 
The present disease is sufficiently different from AD, 
Parkinson’s disease (PD), and amyotrophic lateral scle- 
rosis (ALS) that they need not be considered in the 
differential diagnosis. Ch- 17D shares clinical features 
with Picks disease [32-351, hereditary dysphasic de- 
mentia (HDD) [32],  lobar atrophy 136, 371, pallido- 
pontonigral degeneration (PPND) [38],  progressive 
subcortical gliosis (PSG) [9, 39-42], frontal lobe de- 
generation (FLD) [43, 441, CBD 145, 461, mesolimbo- 
cortical dementia [47],  diffuse L e y  body disease 
(DLBD) [48-501, and parkinsonism-ALS and related 
disorders [51-53]. Ch-17D [I] and familial PSG 141 
are the first frontal lobe dementia syndromes that have 
been linked to chromosome 17, and differ from known 
genetic loci for other dementing disorders, parkinson- 
ism, or motor neuron disease [54-57]. 
The disorders that demonstrate similarities with Ch- 
17D, and therefore should be considered in the differ- 
ential diagnosis, include PSG, CBD and FLD and its 
subtypes [44]. Sporadic and familial PSG shows prefer- 
ential involvement of white matter, usually most severe 
in the frontal lobe [9, 401, variably asymmetrical (9, 
581, and without sharp demarcation between affected 
and unaffected cortices [9]. PSG shares with the pres- 
ent disease severe involvement of the substantia nigra, 
and sparing of the hippocampus and cortical astroglio- 
sis exceeding that expected from the degree of neuronal 
loss [4, 91. However, in the brains studied here, subcor- 
tical gliosis, the hallmark of PSG, was absent. In con- 
trast to the familial PSG patients reported by Lanska 
and colleagues [ 91, the present family members showed 
uniformly moderate to severe involvement of the ros- 
troventral basal ganglia, including ventromedial pal- 
lidum and amygdala. Perhaps the most striking patho- 
logical differences between Ch-17D and PSG were the 
presence of intraneuronal inclusions and GCIs in Ch- 
17D. Petersen and coauthors 141 reported that the two 
kindreds of PSG originally described by Lanska and 
colleagues [9] showed the presence of proteinase K- 
resistant PrP and appear to be allelic to chromosome 
17. This finding raises the possibility that a gene on 
chromosome 17 may be involved in prion metabolism. 
The present study failed to demonstrate proteinase K- 
resistant PrP by immunocytochemistry. This, however, 
does not exclude a possible genetic overlap between 
PSG and Ch-17D [4].  
CBD is a discrete clinicopathological entity. The 
neuropathological abnormalities include frontoparietal 
atrophy with relative sparing of the temporal lobe, bal- 
looned neurons within the cerebral cortex, and variable 
degeneration of subcortical structures, most consis- 
tently affecting the substantia nigra [21,46, 591. Three 
brains affected with CBD reported by Wakabayashi 
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and associates (2 I )  also demonstrated involvement of 
the rostra1 internal and external segments of the globus 
pallidus, putamen, and caudate nucleus, similar to the 
pathology reported here. The same authors demon- 
strated GCIs and subcortical neurofibrillary tangles of 
the PSP type, and hence different from those reported 
here [ 171. The present entity therefore shows consider- 
able overlap with CBD, although differences exist in 
the involvement of the parietal and temporal lobes, and 
the asymmetrical involvement of the pathology in 
CBD [21]. Whether the two entities are genetically 
linked remains to be investigated, although substantial 
clinical differences exist. CBD starts at a later age and 
has a more rapid course [21, 461. 
The cortical changes in Ch-17D are similar to those 
in FLD, although the parietal lobe and the hippocam- 
pus are commonly involved in the latter [43, 441, and 
FLD lacks the neuronal and glial inclusions described 
here. 
Despite substantial overlap in pathology with several 
degenerative dementing disorders, we conclude that the 
present disease shows several distinguishing features, 
such as sharply circumscribed cortical atrophy involv- 
ing limbic structures and association cortices, unique 
intraneuronal inclusions, and lack of subcortical gliosis, 
to regard it, for now, as a separate pathological entity. 
Further genetic analyses of patients with CBD, FLD, 
PPND, or classic Picks disease will be of interest in 
determining whether these diseases are genetically dis- 
tinct or whether they are linked to chromosome 17 as 
are the present disease and PSG [4]. 
In summary, we described the pathology in a famil- 
ial progressive dementing disorder, clinically character- 
ized as disinhibition-dementia-parkinsonism-amyotro- 
phy complex [I]. Study of 6 available brains showed 
a uniform distribution of neuropathological changes. 
The clinical and pathological distinctions between 
multisystem degenerations may at times be difficult, 
and overlapping syndromes may be etiologically related 
[4, 32, 381. Their etiological relationship will require 
determination of the molecular basis for these condi- 
tions. For simplicity and in keeping with the genetic 
characterization of the present disorder, we suggest that 
the clinical and pathologic entity be called “chromo- 
some 17-linked dementia.” 
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